phase readout
saveNCT07540338: A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Alzamend Neuro, Inc.. Phase: PHASE1. Conditions: Bipolar I Disorder
view source ↗
comments(0)
5-min edit window · permanent after that